Specifically, they carried out a cross-sectional study on 122 colorectal cancer patients and evaluated promoter methylation status of six genes (i.e., APC, p14, p16, MLH1, O6-MGMT, and RASSF1A) in tumor biopsies. This evidence concerns the gene MLH1 and neoplasm.